4CPS-234 Impact of an intensive monitoring programme on methotrexate elimination

Autor: C Sebastián, G Castells, A Manzaneque, F Salazar, M Rodrigo, N Meca, J Nicolás
Rok vydání: 2022
Zdroj: Section 4: Clinical pharmacy services.
DOI: 10.1136/ejhpharm-2022-eahp.225
Databáze: OpenAIRE